Dastan, Farzaneh, Salamzadeh, Jamshid, Heshmatnia, Jalal et al. · Iranian journal of pharmaceutical research : IJPR · 2025 · DOI
This study tested whether saffron extract could help reduce extreme tiredness in people who have both COPD (a lung disease) and chronic fatigue syndrome. Researchers gave one group of patients saffron capsules twice daily for 8 weeks, while another group received a placebo (dummy pill). The saffron group showed significant improvement in fatigue and quality of life compared to the placebo group.
This study is relevant because ME/CFS and CFS in COPD patients both involve debilitating fatigue with limited treatment options. Identifying even modest interventions that reduce fatigue burden without adverse effects could improve quality of life for patients with severe, unexplained chronic fatigue. The rigorous RCT design provides stronger evidence than observational studies for evaluating potential adjunctive treatments.
This study does not prove saffron is effective for ME/CFS in the general population, as participants were specifically COPD patients with secondary fatigue—a potentially different condition from primary ME/CFS. The study cannot determine the mechanism of saffron's action or whether benefits would persist beyond 8 weeks. It also does not establish whether saffron addresses post-exertional malaise or other ME/CFS-specific symptoms.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Spotted an error in this entry? Report it →